Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study

Objectives As-needed low-dose combination budesonide-formoterol is recommended by asthma guidelines in many countries as an alternative to maintenance inhaled corticosteroids (ICS) for treatment of mild asthma, but there are few data on patient attitudes toward these regimens. This study explored the comparative implementation experiences and future treatment preferences of mild asthma patients who had experienced these two treatment regimens. Setting A subgroup of adults randomised to maintenance ICS or as-needed ICS-formoterol in a multinational, 52-week open-label randomised controlled trial (NovelSTART) in mild asthma patients were interviewed to explore their motivations for treatment use during the study and their preferences for future treatment. Participants Semistructured interviews were conducted with 74 participants (Maintenance group: n=39, As-needed group n=35, mean age 38 (range 19–69)) and thematically analysed from transcribed audiorecordings. Results Emergent themes from analysis comprised: ‘How much my asthma affects me’ (how their asthma’s impact affected their self-management motivation); ‘What I know about asthma’ (limited knowledge impeded appropriate self-management decision making); ‘How much effort this treatment regimen involves for me’ (treatment complexity and/or difficulty establishing a medication routine impeded implementation, particularly in the Maintenance group); and ‘My beliefs about the benefits and risks of this treatment’ (patients who considered their treatment as ineffective, eg, limited difference in symptoms relative to salbutamol (both groups) or slower onset of relief (As-needed group) had poor motivation to use the treatment). Due to the simplicity of the as-needed combination strategy, this was the preferred future regimen, even by patients who had not yet tried it. Conclusions Key patient perspectives on the implementation of preventer treatments for mild asthma included factors relating to perceived asthma burden, disease knowledge, treatment complexity and treatment usefulness or safety. The as-needed budesonide-formoterol regimen was preferred to maintenance ICS treatment in mild asthma though patient education is urgently needed to address implementation motivation. Trial registration number ACTRN12615000999538.

[1]  M. Weatherall,et al.  ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis , 2021, ERJ Open Research.

[2]  I. Pavord,et al.  Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma , 2020, European Respiratory Journal.

[3]  I. Pavord,et al.  Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study. , 2020, Respiratory medicine.

[4]  M. Harwood,et al.  Patient preferences for asthma management: a qualitative study , 2020, BMJ Open.

[5]  R. Hancox,et al.  What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment , 2020, Thorax.

[6]  I. Pavord,et al.  The burden of exacerbations in mild asthma: a systematic review , 2020, ERJ Open Research.

[7]  G. Harper,et al.  Identifying the drivers of patients’ reliance on short-acting β2-agonists in asthma , 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

[8]  R. Hancox,et al.  Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial , 2020, European Respiratory Journal.

[9]  R. Horne,et al.  Pharmacist-led adherence support in general practice: a qualitative interview study of adults with asthma , 2019, BMJ Open.

[10]  R. Hancox,et al.  Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial , 2019, The Lancet.

[11]  A. Sheikh,et al.  GINA 2019: a fundamental change in asthma management , 2019, European Respiratory Journal.

[12]  I. Pavord,et al.  Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. , 2019, The New England journal of medicine.

[13]  Lorraine D Smith,et al.  ‘It’s a powerful message’: a qualitative study of Australian healthcare professionals’ perceptions of asthma through the medium of drawings , 2019, BMJ Open.

[14]  Eva M. Raebel,et al.  Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence. , 2018, Respiratory medicine.

[15]  E. Bateman,et al.  As‐Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma , 2018, The New England journal of medicine.

[16]  E. Bateman,et al.  Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma , 2018, The New England journal of medicine.

[17]  W. Busse,et al.  Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study , 2017, The Lancet.

[18]  I. Pavord,et al.  Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma , 2016, European Respiratory Journal.

[19]  N. Freemantle,et al.  Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework , 2013, PloS one.

[20]  C. Rand,et al.  Identifying patient‐specific beliefs and behaviours for conversations about adherence in asthma , 2012, Internal medicine journal.

[21]  Johnny Saldaña,et al.  The Coding Manual for Qualitative Researchers , 2009 .

[22]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  C. Delacourt,et al.  Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations , 2007, Allergy.

[24]  W. Busse,et al.  Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study , 2006, BMC pulmonary medicine.

[25]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[26]  A. Huberman,et al.  Qualitative Data Analysis: A Methods Sourcebook , 1994 .

[27]  B. Rodgers,et al.  The qualitative research audit trail: a complex collection of documentation. , 1993, Research in nursing & health.